Biotronik in first coronary implant of absorbable stent:
This article was originally published in Clinica
Executive Summary
Biotronik has taken a step forward in its bid to take its absorbable metal stent (AMS) to the coronary artery disease market. It has conducted the first human implant of the device, as part of its PROGRESS-AMS study. The product's safety has already been confirmed in below-the-knee arteries - the first human implant for this indication took place in December 2003, said the Berlin, Germany firm. Commenting on the coronary implant, the company said that four-month follow-up would be needed to determine the potential of the technology and to validate its expectations of moving the technology into the boundaries of coronary stenting.